Solving Drug Resistance in Cancer

Today, systemic cancer treatments are limited by a 1% tumor delivery rate.

We are engineering precision tools to remodel the Tumor Microenvironment.

Achieve predictable Target Engagement. Where it matters most.

Find out more about our solution.